Literature DB >> 17098112

Electrocardiographic applications of lead aVR.

Kelly Williamson1, Amal Mattu, Claire U Plautz, Allan Binder, William J Brady.   

Abstract

Lead aVR, 1 of 12 electrocardiographic leads, is frequently ignored in clinical medicine. In fact, many clinicians refer to the 12-lead electrocardiogram (ECG) as the 11-lead ECG, noting the commonly held belief that lead aVR rarely offers clinically useful information. In this report, we discuss the findings in lead aVR, which are potentially of value, including ST-segment elevation in the patient with acute coronary syndrome suggestive of left main coronary artery occlusion, PR-segment elevation in the patient with acute pericarditis, prominent R wave in the patient with significant tricyclic antidepressant poisoning, and ST-segment elevation in narrow complex tachycardia suggestive of Wolff-Parkinson-White syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098112     DOI: 10.1016/j.ajem.2006.05.013

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

Review 1.  Clinical value of lead aVR.

Authors:  Andrés Ricardo Pérez Riera; Celso Ferreira; Celso Ferreira Filho; Sergio Dubner; Raimundo Barbosa Barros; Francisco Femenía; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

2.  Image diagnosis: aVR, the forgotten lead.

Authors:  Donald P Mebust
Journal:  Perm J       Date:  2015

3.  Optimal ECG-lead selection increases generalizability of deep learning on ECG abnormality classification.

Authors:  Changxin Lai; Shijie Zhou; Natalia A Trayanova
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2021-10-25       Impact factor: 4.226

4.  Flecainide toxicity in renal failure.

Authors:  Rogin Subedi; Ryan K Dean; Arbind Chaudhary; Tamas Szombathy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-09

5.  Relationship between ST-Segment Shifts in Lead aVR and Coronary Complexity in Patients with Acute Coronary Syndrome.

Authors:  Adem Adar; Orhan Onalan; Fahri Cakan
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

Review 6.  Evaluating the Impact of COVID-19 on a Regional Primary Percutaneous Coronary Intervention Service During the First Wave of COVID-19.

Authors:  Adeogo Akinwale Olusan; Peadar Devlin
Journal:  Interv Cardiol       Date:  2022-04-04

7.  Serial Monitoring of Lead aVR in Patients with Prolonged Unconsciousness Following Tricyclic Antidepressant Overdose.

Authors:  Kyoung Ho Choi; Kyoung-Uk Lee
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.